Breaking

The Real Drivers of This Market: AI, Semis & Robotics
S&P 500 Breaking Out Again: What This Means for Your Portfolio
RAD receives IND approval from US FDA for Betabart (RV-01)
Maiden Drill Program Commences at Oasis Uranium Project
Asara raises $25m to accelerate exploration at Kada
Completion of Silver Acquisition & Appointment of New Managing Director
Comet share sale and debt repayment
Agreement to Develop New Expandable Graphite Facility

Business
Investing
Stocks
Latest News
Search for:

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Maiden Drill Program Commences at Oasis Uranium Project

Agreement to Develop New Expandable Graphite Facility

Comet share sale and debt repayment

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Disclaimer: marketruleexperts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 marketruleexperts.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.